YME1L1 and acute kidney injury: Consequently, multiple studies have targeted mitochondrial dysfunction as a therapeutic approach for AKI.[4, 5, 18] In this study, we screened and identified that YME1L1, a key protein in the inner mitochondrial membrane,[19] downregulated in PTECs under AKI conditions both in vitro and in vivo.